These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1578517)

  • 1. I-131 NP-59 adrenal cortical scintigraphy in suspected primary aldosteronism.
    Kao CH; Liao SQ; Wang SJ; Lin MS; Hsu CY; Lin WY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Apr; 8(4):213-8. PubMed ID: 1578517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy and pitfalls of [iodine-131]6-beta-iodomethyl-19-norcholesterol (NP-59) imaging.
    Kazerooni EA; Sisson JC; Shapiro B; Gross MD; Driedger A; Hurwitz GA; Mattar AG; Petry NA
    J Nucl Med; 1990 Apr; 31(4):526-34. PubMed ID: 2324830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenal imaging with iodomethyl-norcholesterol (I-131) in primary aldosteronism.
    Freitas JE; Grekin RJ; Thrall JH; Gross MD; Swanson DP; Beierwaltes WH
    J Nucl Med; 1979 Jan; 20(1):7-10. PubMed ID: 430181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adrenal cortex scintigraphy with and without dexamethasone suppression in the study of primary aldosteronism].
    Milà López M; Castell-Conesa J; Pifarré Montaner P; Lorenzo Bosquet C; García-Burillo A; Porta Biosca F; Roca Bielsa I
    Rev Esp Med Nucl; 2004; 23(5):324-9. PubMed ID: 15450137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenal imaging with iodomethyl-norcholesterol (I-131) in primary aldosteronism.
    Gordon L; Levine JH; Mayfield RK; Buse MG
    J Nucl Med; 1979 Aug; 20(8):897-8. PubMed ID: 541739
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic value of adrenal iodine-131 6-beta-iodomethyl-19-norcholesterol scintigraphy for primary aldosteronism: a retrospective study at a medical center in North Taiwan.
    Wu MH; Liu FH; Lin KJ; Sun JH; Chen ST
    Nucl Med Commun; 2019 Jun; 40(6):568-575. PubMed ID: 30694876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenal cortical scintigraphy for lateralization of bilateral adrenal nodules in primary aldosteronism.
    Hwang I; Chong A; Kim JB; Kim KH; Kwon D
    Korean J Urol; 2014 Aug; 55(8):551-3. PubMed ID: 25132951
    [No Abstract]   [Full Text] [Related]  

  • 8. Adrenal imaging with 131I-adosterol (NCL-6-131I) by diverging and pinhole methods. III. Comparative studies of baseline and dexamethasone suppression imaging in aldosteronism.
    Nakajo M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Apr; 42(4):380-8. PubMed ID: 7122228
    [No Abstract]   [Full Text] [Related]  

  • 9. Adrenocortical SPECT using iodine-131 NP-59.
    Hwang I; Balingit AG; Georgitis WJ; Sisson JC; Shapiro B
    J Nucl Med; 1998 Aug; 39(8):1460-3. PubMed ID: 9708530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nuclear medicine methods for the diagnosis of adrenal tumors].
    Gregianin M; Bui F; Varotto L; Zucchetta P; Macri C
    Minerva Endocrinol; 1995 Mar; 20(1):27-38. PubMed ID: 7651280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a role for Nuclear Medicine in diagnosis and management of patients with primary aldosteronism?
    Spyridonidis TJ; Apostolopoulos DJ
    Hell J Nucl Med; 2013; 16(2):134-9. PubMed ID: 23865085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenal scintiscanning with NP-59, a new radioiodinated cholesterol agent.
    Miles JM; Wahner HW; Carpenter PC; Salassa RM; Northcutt RC
    Mayo Clin Proc; 1979 May; 54(5):321-7. PubMed ID: 431134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary aldosteronism and hyperandrogenism.
    Macrì C; Gregianin M; Bui F
    Rays; 1992; 17(1):49-61. PubMed ID: 1636018
    [No Abstract]   [Full Text] [Related]  

  • 14. NP-59 test for preoperative localization of primary hyperaldosteronism.
    Di Martino M; García Sanz I; Muñoz de Nova JL; Marín Campos C; Martínez Martín M; Domínguez Gadea L
    Langenbecks Arch Surg; 2017 Mar; 402(2):303-308. PubMed ID: 28224279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited significance of asymmetric adrenal visualization on dexamethasone-suppression scintigraphy.
    Gross MD; Shapiro B; Freitas JE
    J Nucl Med; 1985 Jan; 26(1):43-8. PubMed ID: 2981301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unilateral adrenal hyperplasia causing primary aldosteronism: limitations of I-131 norcholesterol scanning.
    Mansoor GA; Malchoff CD; Arici MH; Karimeddini MK; Whalen GF
    Am J Hypertens; 2002 May; 15(5):459-64. PubMed ID: 12022249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal scintigraphy in primary aldosteronism. Spironolactone as a cause of incorrect classification between adenoma and hyperplasia.
    Fischer M; Vetter W; Winterg B; Zidek W; Vetter H
    Eur J Nucl Med; 1982; 7(5):222-4. PubMed ID: 7094925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interference by spironolactone on adrenocortical scintigraphy and other pitfalls in the location of adrenal abnormalities in primary aldosteronism.
    Shapiro B; Grekin R; Gross MD; Freitas JE
    Clin Nucl Med; 1994 May; 19(5):441-5. PubMed ID: 8039321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of adrenal gland iodomethylnorcholesterol uptake to zona glomerulosa function in primary aldosteronism.
    Gross MD; Shapiro B; Grekin RJ; Meyers L; Swanson DP; Beierwaltes WH
    J Clin Endocrinol Metab; 1983 Sep; 57(3):477-81. PubMed ID: 6874887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NP-59 Adrenal Scintigraphy as an Imaging Biomarker to Predict
    Lu CC; Yen RF; Peng KY; Huang JY; Wu KD; Chueh JS; Lin WY
    Front Endocrinol (Lausanne); 2021; 12():644927. PubMed ID: 33995277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.